Influence
December 17, 2024

Regenstrief researcher on author list for 1 of JAMA’s 2024 most viewed papers

Sarah Wiehe, MD

A paper co-authored by Regenstrief Research Scientist Sarah Wiehe, M.D., M.P.H., as a member of the U.S. Preventive Services Task Force (USPSTF), is one of 2024’s most viewed papers from the well-respected Journal of the American Medical Association (JAMA).  

The article, “Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement,” was among the top 10 for 2024 and was announced on Tuesday, December 17, 2024.The updated guidelines emphasize the importance of biennial mammography screening for women aged 40 to 74 years to reduce breast cancer-related deaths. 

Breast cancer remains the second most common cancer and cause of cancer death among women in the United States. The new recommendations suggest starting regular mammography screenings at age 40 to achieve a moderate net benefit in reducing breast cancer mortality. 

Dr. Wiehe was appointed to serve a four-year term on the task force in January of 2024. Task force members are appointed by the secretary of Health and Human Services. 

On the task force, Dr. Wiehe works to improve the health of people nationwide by making evidence-based recommendations about clinical preventive services. Because the task force is an independent, volunteer panel of national experts in prevention and evidence-based medicine, they are equipped to suggest services such as screenings, counseling services and preventive medications. 

The task force’s updated recommendation is a shift that prioritizes earlier screening, particularly given breast cancer’s continued impact across diverse populations. Non-Hispanic Black women, who experience the highest breast cancer mortality rate, stand to benefit from efforts to improve access to and adherence to recommended screenings. 

Sarah Wiehe, M.D., MPH  

In addition to her role as a research scientist with the William M. Tierney Center for Health Services Research at Regenstrief Institute, Sarah Wiehe, M.D., MPH, is the co-director of the Indiana Clinical and Translational Sciences Institute. She is a professor of pediatrics, associate dean for community and translational research, the Jean and Jerry Bepko Scholar in Pediatrics, and the chief of the Division of Children’s Health Services Research at Indiana University School of Medicine. Dr. Wiehe is also an adjust associate professor at the Indiana Richard M. Fairbanks School of Public Health at IU Indianapolis. 

Related News

Dr. Babar Khan on All IN

Renowned delirium researcher and clinician named Regenstrief interim center director

Babar Khan, M.D., M.S., a renowned delirium research scientist and pulmonary and critical care clinician, has been named interim

Regenstrief Research Scientist Wanzhu Tu, PhD

Parental liver disease death more than doubles risk of alcohol-associated hepatitis in next generation

In a groundbreaking study, research scientists from the Indiana University School of Medicine and Regenstrief Institute found that individuals

image of elderly woman discussing pill bottle with her doctor

American Geriatrics Society unveils updated alternatives to potentially harmful medications for older adults

Regenstrief researcher serves on expert panel providing clinicians, patients and families with credible, actionable alternatives The American Geriatrics Society

LOINC version 2.81 release

Arabic and Czech translations, more than 4,000 new concepts boost global interoperability in latest LOINC® release

Regenstrief Institute’s latest LOINC® content update on August 12, introduces two new linguistic variants: Arabic, for users in Jordan,